CLINICAL_TRIALS
research
· 2026-01-07
Clinical Trial Update: A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Summary
Pfizer is enrolling pediatric patients in India to study somatrogon for growth hormone deficiency.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Dwarfism, Pituitary | Status: RECRUITING